Beyond Air (XAIR) Liabilities and Shareholders Equity (2015 - 2026)
Beyond Air's (XAIR) quarterly Liabilities and Shareholders Equity came in at $32.9 million in Q2 2026, up 16.99% year-over-year from $28.1 million in Q2 2025, and down 7.05% quarter-over-quarter from $35.4 million in Q1 2026.
Analysis
Beyond Air (XAIR) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
Beyond Air has disclosed Liabilities and Shareholders Equity across 12 years of filings, most recently posting $32.9 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 16.99% year-over-year to $32.9 million; the TTM figure through Jun 2026 stood at $136.0 million (down 6.41% YoY), while the FY2026 annual figure was $35.4 million, up 17.71% from the prior year.
- Liabilities and Shareholders Equity came in at $32.9 million for Q2 2026 at Beyond Air, down from $35.4 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $99.2 million in Q1 2022 to a low of $28.1 million in Q2 2025.
- Average Liabilities and Shareholders Equity over 5 years is $54.6 million, with a median of $52.5 million recorded in 2023.
- Year-over-year, Liabilities and Shareholders Equity surged 144.78% in 2022 and plunged 47.22% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $74.0 million in 2022, then fell by 29.81% to $51.9 million in 2023, then slumped by 34.23% to $34.1 million in 2024, then gained by 7.7% to $36.8 million in 2025, then dropped by 10.56% to $32.9 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $32.9 million in Q2 2026, $35.4 million in Q1 2026, and $36.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.63 Bn | 175.03 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 127.57 Bn | 122.36 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 116.86 Bn | 108.04 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 104.03 Bn | 100.55 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 63.67 Bn | 63.14 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 20.70 Bn | 20.22 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Beyond Air | 2.24 Mn | -8.68 Mn | 225,000.00 | 32.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.89 Mn |
| Mar 31, 2026 | 35.39 Mn |
| Dec 31, 2025 | 36.77 Mn |
| Sep 30, 2025 | 30.97 Mn |
| Jun 30, 2025 | 28.11 Mn |
| Mar 31, 2025 | 30.06 Mn |
| Dec 31, 2024 | 34.14 Mn |
| Sep 30, 2024 | 53.01 Mn |
| Jun 30, 2024 | 46.50 Mn |
| Mar 31, 2024 | 56.96 Mn |
| Dec 31, 2023 | 51.91 Mn |
| Sep 30, 2023 | 58.01 Mn |
| Jun 30, 2023 | 73.04 Mn |
| Mar 31, 2023 | 68.75 Mn |
| Dec 31, 2022 | 73.96 Mn |
| Sep 30, 2022 | 82.04 Mn |
| Jun 30, 2022 | 91.90 Mn |
| Mar 31, 2022 | 99.20 Mn |
| Dec 31, 2021 | 99.31 Mn |
| Sep 30, 2021 | 54.06 Mn |